Projects per year
Personal profile
Personal profile
Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.
Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.
Research Area Keywords
- Cancer
- Clinical Translation & Trials
- Molecular Medicine
Fingerprint
Dive into the research topics where S. Ravi Pingali is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
9/21/22 → …
Project: Clinical Trial
-
ER stress response and chronic lymphocytic leukemia
Hu, C. A., Pingali, S. R. & Tang, C. A.
9/3/21 → …
Project: Clinical Trial
-
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Sepsis Prediction with Deep Learning and Wearable Monitoring Patch'd
Pingali, S. R., Ganguly, S., Gotur, D. B., Jones, S. L., Masud, F. N. & Shah, S.
7/14/21 → …
Project: Clinical Trial
-
Prognostic Effect of Systemic Therapy and Radiation Therapy in Stage I Nodal Marginal Zone Lymphoma
Chevli, N., Margolis, V., Haque, W., Pingali, S. R., Butler, E. B. & Teh, B. S., Jan 1 2023, In: Practical Radiation Oncology. 13, 1, p. e80-e93Research output: Contribution to journal › Article › peer-review
-
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Su, P., Xiao, L., Ye, L., Wang, Z., Xiong, W., Wang, Q., Ma, X., Xian, M., Yang, M., Zu, Y., Pingali, S. R., Qian, J. & Yi, Q., Dec 2022, In: Journal of Hematology and Oncology. 15, 1, 55.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
Sirimaturos, M., Gotur, D. B., Patel, S. J., Dreucean, D., Jakowenko, N., Cooper, M. H., Brahmbhatt, N., Graviss, E. A., Nguyen, D. T., Pingali, S. R., Lin, J. & Musick, W. L., 2022, In: Critical Care Explorations. 2, 10, p. E0232Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Loss of AID exacerbates the malignant progression of CLL
Lee, A. C., Pingali, S. R., Pinilla-Ibarz, J. A., Atchison, M. L., Koumenis, C., Argon, Y., Thomas-Tikhonenko, A., De Trez, C., Hu, C. C. A. & Tang, C. H. A., Oct 2022, In: Leukemia. 36, 10, p. 2430-2442 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway
Wang, Q., Lin, Z., Wang, Z., Ye, L., Xian, M., Xiao, L., Su, P., Bi, E., Huang, Y. H., Qian, J., Liu, L., Ma, X., Yang, M., Xiong, W., Zu, Y., Pingali, S. R., Xu, B. & Yi, Q., Jan 6 2022, In: Blood. 139, 1, p. 59-72 14 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations